Objective: Ascending aortic aneurysms (AAA) are a leading cause of morbidity and mortality. Nevertheless, their effects on global cardiac functions are yet to be fully understood. Myocardial performance index (MPI) has been widely used to quantitatively assess myocardial functions. The aim of this study was to evaluate left ventricular (LV) functions in patients with AAA using tissue Doppler (TD) echocardiography and MPI in addition to conventional echocardiographic methods.
A ortic aneurysms (AA) are a leading cause of morbidity and mortality in individuals >55 years of age. [1] Most are diagnosed in an imaging study performed for an unrelated indication. Although it is a relatively rare pathology when compared with other cardiovascular disorders, the extensive complications of untreated or undiagnosed aneurysms elevate its clinical importance. [2] The aorta has an elastic structure and is generally affected by aging, atherosclerosis, hypertension (HT), and diabetes mellitus (DM). [3, 4] Changes in the elastic structure caused by these risk factors are reflected by a decrease in aortic distensibility (AD), reduced aortic elasticity, and increased aortic stiffness. [5] Reduced aortic elasticity causes an increase in aortic pulse pressure (PP), left ventricular (LV) afterload, and LV hypertrophy, which may lead to impairment in cardiac functions. [6] However, to the best of our knowledge, little information is available regarding changes in cardiac functions in patients with AA.
Myocardial performance index (MPI) has been widely used to quantitatively assess myocardial functions. [7] It is likely to be more effective for analysis of global cardiac function than systolic and diastolic measures alone. [8, 9] MPI obtained by tissue Doppler (TD) echocardiography may also give a better reflection of global LV function than an isolated evaluation of either ejection or relaxation. [10] The value of TD-MPI to assess LV function in patients with ascending aortic aneurysms (AAA) has not yet been investigated. The aim of this study was to investigate LV function and MPI by TD echocardiography, and to evaluate the relationship of AD with MPI in the assessment of LV function in patients with AAA.
METHODS
Study population was prospectively recruited from consecutive outpatients with AAA diagnosis who underwent coronary angiography with various indications. Of the 268 patients with AAA enrolled, 218 were excluded due to abnormal coronary angiography; only patients with normal angiography were included. The final group consisted of 50 patients with AAA (enddiastolic proximal ascending aorta diameter >40 mm) in the absence of concomitant coronary artery disease (33 men, 17 women; mean age 55.5±7.90 years). A total of 106 patients without aortic dilatation and with normal coronary angiography (mean age 54.1±8.18 years) were selected as the control group. Patients with moderate and severe valvular heart disease, history of myocardial infarction, wall motion abnormalities, heart failure, severe pulmonary disease, major non-cardiovascular diseases, cerebrovascular disease, and renal insufficiency (serum creatinine >1.5 mg/dL in men and >1.4 mg/dL in women) were excluded. Patients with secondary etiologic disorders, such as genetically triggered aneurysms, inflammatory diseases, or trauma-associated aneurysms were excluded, as were those with bicuspid aortic valves and coarctation of the aorta. Only patients with isolated idiopathic or degenerative AAA were included.
After detailed medical histories were obtained, each participant underwent complete physical examination and was questioned for major cardiovascular risk factors such as age, sex, DM, smoking status, and HT. In addition, systolic blood pressure (SBP), diastolic blood pressure (DBP), and initial heart rate were recorded. All patients underwent electrocardiography, and comprehensive transthoracic Doppler and TD echocardiography. The study was conducted according to recommendations set forth by the Declaration of Helsinki on medical research involving human subjects. The institutional ethics committee approved the study protocol, and each participant provided written informed consent.
Echocardiography
Standard 2-dimensional, M-mode, and TD echocardiographic examinations were performed using commercially available equipment (Vivid-7; GE Vingmed Ultrasound, Horten, Norway) with a 2.5-3.5 MHz transducer. Simultaneous electrocardiographic recordings were also obtained. An echocardiographer blinded to clinical and laboratory data interpreted each echocardiographic examination independently. LV ejection fraction (LVEF) was determined using Simp- [11] LV end-diastolic diameter, LV end-systolic diameter, end-diastolic left atrial diameter, end-diastolic interventricular septum (IVS), and left posterior wall (PW) thickness were measured using M-mode echocardiography. Sample volume of pulsed-wave Doppler was placed between the tips of the mitral leaflets in the apical 4-chamber view. Early (E) and late (A) transmitral flow velocities, as well as the ratio of early to late peak velocities (E/A) were obtained. Mitral pulsed-wave Doppler time intervals were measured from mitral inflow and left ventricular outflow Doppler tracings, as described by Tei and colleagues. [7] Three consecutive beats were measured and averaged for each parameter. Isovolumic relaxation time (IVRT) was measured from the closure of the aortic valve to the opening of the mitral valve. Isovolumic contraction time (ICT) was measured from the closure of the mitral valve to the opening of the aortic valve. Ejection time (ET) was measured from the opening to the closure of the aortic valve on the LV outflow velocity profile (MPI=[IVRT+ICT]÷ET).
After proper acquisition adjustments were made, left ventricle tissue Doppler echocardiography (TDE) evaluation was performed in apical 4-chamber position by placing the pulsed-wave Doppler beam on section of the mitral annulus close to the left ventricle lateral wall and the IVS. Special attention was paid during recordings to place the Doppler beam in the myocardium, not the endocardium or epicardium. Measurements were made for 3 consecutive heartbeats in all positions, and their average was taken. Doppler measurements were made at a recording rate of 100 mm/sec. Average of the septal and lateral annular mitral early diastolic (e'), late diastolic (a'), and systolic (Sm) spectral TD velocities, as well as the E/e' and e'/a' ratios, were measured. MPI obtained by TDE was defined as (IVRT+ICT)÷ET ( Figure 1 ). All echocardiograms were recorded and interpreted online on hard disks for offline analysis by another observer blinded to patient data. Intra-and interobserver variability of echocardiographic data were evaluated from 15 randomly selected patients with AAA and calculated as the absolute difference divided by the average of the 2 observations. Mean intra-and interobserver variability were 3.3±2.14% and 3.9±2.71%, respectively.
Calculation of aortic root parameters
Aortic root systolic diameter (AoSD) and aortic root diastolic diameter (AoDD) were measured by M-mode at a level of 3-4 cm above the aortic valve from a transthoracic parasternal long-axis view at the time of maximum aortic anterior motion and at the peak of the QRS complex, respectively. Two-dimensional measurements of the aortic root end-diastolic dimensions were made in the parasternal long-axis views at 4 levels: the annulus (defined echocardiographically as the hinge points of the aortic cusps), the sinuses of Valsalva, the supra-aortic ridge, and the proximal ascending aorta. The measurements were made perpendicular to the long axis of the aorta using the leading edge technique in views showing the largest aortic diameters. [12] Diagnosis of AA was determined solely from morphologic analysis of the aorta, and dilation was suspected in the case of an aortic root dimension at the sinuses of Valsalva greater than the upper limit of the 95% confidence interval of the overall distribution.
Blood pressure was measured by arm sphygmomanometer. The indices of aortic root mechanics were calculated as AD=2×(pulsatile change in aortic diameter)/([diastolic aortic diameter]×[PP]). [13] PP was obtained simultaneously by cuff sphygmomanometry of the left brachial artery as (SBP-DBP).
Statistical analysis
Analyses were performed using SPSS software (version 20.0; SPSS Inc., Chicago, IL, USA). Continu- ics, and other echocardiographic parameters were assessed by Spearman correlation analysis. All parameters with p<0.10 in univariate analysis were selected in the multivariate model. To avoid overfitting and collinearity in assessing the multivariate model, independent variables were tested for intercorrelation. Collinearity between variables was excluded before modeling. AD, IVS, creatinine, and E/A ratio were selected in multivariate linear regression model, which was used to determine independent predictors ous variables were expressed as mean±SD or median (min-max) where applicable. Number of cases and percentages were used for categorical data. Continuous variables were tested for normality using the Kolmogorov-Smirnov test. While mean differences between groups were compared using Student's t-test, Mann-Whitney U test was applied for comparisons of medians. Categorical data were analyzed by Pearson's chi-square test. Correlations between aortic distensibility, TD-MPI, laboratory data, hemodynam- of TD-MPI. A two-tailed p<0.05 was considered statistically significant.
RESULTS
Baseline clinical and laboratory characteristics of patients with AAA, as well as those of the control group, are presented in Table 1 . The laboratory findings of the 2 groups were similar (p>0.05 for all), except for high-density lipoprotein, triglyceride, and creatinine levels.
Echocardiographic data
Echocardiographic data are presented in Table 2 . Table 2 ).
Analysis of pulse pressure and aortic distensibility
Aortic distensibility was significantly lower in patients with AAA than in control subjects (1.7±1.27 vs 3.1±1.25, p<0.001; 
Correlations and multivariate associations of TD-MPI
Correlations of TD-MPI in patients with AAA are presented in Table 4 . In patients with AAA, the adjusted TD-MPI had significant inverse relations with aortic distensibility (r=-0.501, p<0.001) and positive corre- Figure 2 .
There were increased LV thickness, SBP, and PP in the patient group. When adjusted for these variables, both MPI and TD-MPI were independent of SBP, finding of our study is the negative and independent correlation between TD-MPI and aortic distensibility. The aorta has an elastic structure and is generally affected by aging, atherosclerosis, HT, and DM. [3, 14] Changes in the elastic structure caused by these risk factors are reflected by a decrease in AD, reduced aortic elasticity, and increased aortic stiffness. [15] Aortic stiffening leads to an increase in central SBP, and a decrease in DBP with an increase in PP. An altered SBP may increase LV afterload with an increase in myocardial oxygen demand, LV hypertrophy, fibrosis, and eventually an impairment in cardiac functions. [6] It has been reported in several studies that LV diastolic function was severely reduced in patients with chronic aortic dissection, and aortic stiffness was augmented in patients with aortic aneurysm, which could be a result of elevated LV afterload. [5] It has also been shown that elevated afterload was one of the major causes of LV diastolic dysfunction. [16] In our population, diastolic dysfunction, LV hypertrophy, and decrease in AD were observed in patients with AAA in accordance with these previous reports, whereas systolic functions such as LV ejection fraction and Sm remained unchanged. Therefore, this impairment of global cardiac function in patients with AAA is predominantly the consequence of diastolic dysfunction, which is primarily related to LV hypertrophy and reduced aortic elasticity.
Another explanation for impaired global cardiac function indicated by TD-MPI in patients with AAA may include microvascular dysfunction. Myocardial perfusion depends on the diastolic pressure gradient from epicardium to endocardium and the duration of diastole. A decrease in DBP can compromise myocardial perfusion, resulting in subendocardial ischemia. [17] Other mechanisms of microvascular dysfunction in AAA may involve vascular remodeling, reduced capillary density, and elevated LV end-diastolic pressure, which causes perfusion abnormalities, predominantly in subendocardial layers of myocardium because of increased afterload. [18] Furthermore, arterial distensibility and stiffness are abnormal in aneurysmal arteries, and aortic stiffening is an important complication in patients with AA. [19] Previous studies have shown that coronary flow velocity reserve (CFVR) is impaired in patients with aortic stiffness. [20] In a recent study, we demonstrated that that noninvasive CFVR was significantly impaired in patients with AAA, compared with controls, and that AoSD is the strongest predic-
DISCUSSION
To the best of our knowledge, this was the first study to investigate LV function and MPI using TDE, and evaluate the relationship between AD and LV function in patients with AAA. Our study demonstrated that MPI-and TD-MPI-indicated global cardiac functions were impaired in patients with AAA. A significant relationship between TD-MPI and AD was also found. In the present study, both systolic and diastolic functions were assessed using TDE in addition to conventional echocardiographic methods. MPI, which was calculated using data obtained from PW Doppler and TD echocardiography, was also used to assess LV functions. Results of our study showed that both MPI and TD-MPI were significantly higher in patients with AAA. An important limitation was the interval between the end and the onset of mitral inflow and ET being measured sequentially, not on the same cardiac cycle, by conventional pulsed-wave Doppler echocardiography. However, TDE as used in the present study could simultaneously record systolic and diastolic mitral annular velocities. Determination of MPI obtained by TDE requires measurement of only 2 simple intervals on the same cardiac cycle.
Results of the present study support the view that diastolic and systolic dysfunction may be more common in patients with AAA by TDE, compared with the control group. The mechanism of this impaired LV dysfunction remains unknown. One interesting been shown to provide valuable information on crosssectional coronary vascular structure with high spatial resolution. [26] Therefore, in this group of patients, vulnerable coronary plaques cannot be ruled out completely. Secondly, although the study population had medical conditions that may affect myocardial performance such as DM, HT, and hyperlipidemia, or were taking medications, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, β-receptor blockers, and statins, there were no differences in the proportion of patients with these medical conditions or on these medications between groups. Thirdly, TD-MPI was used to determine global cardiac functions. Although TD-MPI was validated in several previous reports, there are more accurate and reliable methods, such as Speckle tracking or 3-dimensional echocardiography. Therefore, future studies using Speckle tracking and 3-dimensional echocardiography would be more informative in assessing the relationship between aortic aneurysms, cardiac functions, and aortic stiffness. Lastly, variables such as MPI and AD may be influenced by aortic regurgitation. As patients with moderate and severe valvular heart disease were excluded, we think it is unlikely that mild aortic disease affected the results of the present study.
Conclusion
The present study demonstrated that MPI-and TD-MPI-indicated global cardiac functions are significantly impaired in patients with AAA. This impairment of cardiac function is predominantly the consequence of decreased aortic distensibility and reduced aortic elasticity. As a consequence, our data indicate that parameters describing LV workload, LV hypertrophy, diastolic dysfunction, and AD are related to key mechanisms responsible for impaired TD-MPI in patients with AAA.
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tor of impaired CFVR. [21] Therefore, reduced CFVR, which reflects microvascular dysfunction, may lead to myocardial ischemia and impaired cardiac functions.
It has been reported that aortic root diameter, especially at the level of the sinuses of Valsalva, may be related to body surface area and body mass index (BMI). [11] Aortic root diameters were not indexed according to BMI, but there were no statistical significant differences between patients and controls. Moreover, after multivariate regression analysis, the relation between TD-MPI and AD was observed to persist, even after adjustment for BMI in patients with AAA.
Compared with the healthy population, the value of MPI and TD-MPI were slightly higher in the control group, while AD was slightly lower. A direct comparison with the present study is difficult because the control group consisted of patients with DM, HT, and hyperlipidemia, rather than healthy subjects, to provide clinical match with AAA patients. Several previous studies demonstrated that in patients with DM, HT, and hyperlipidemia, MPI and AD might be impaired, even with a normal coronary angiography. [22, 23] Moreover, Sahin et al. demonstrated that MPI and AD were strongly associated with LV geometry in patients with HT. [24] Hence, our results are consistent with previous reports.
Clinical implications
AAA may lead to global cardiac dysfunction as indicated by TD-MPI before LVEF impairment. According to results of the present study, this cardiac dysfunction is predominantly the consequence of decreased aortic distensibility and reduced aortic elasticity. Aortic distensibility and stiffness have been demonstrated to be reduced by several medications, such as certain antihypertensive agents, statins, and thiazolidinediones, as well as by lifestyle modification. [25] Therefore, long-term medical treatment and lifestyle modification in patients with AAA may prevent cardiac dysfunction and the enlargement of the aorta by reducing aortic distensibility.
Study limitations
Several limitations of the present study should be mentioned. Conventional coronary angiography was used to exclude coronary artery disease instead of more accurate methods, such as intravascular ultrasonography or optic coherence tomography, which have
